Zahra Ojaghi-Haghighi1, Bahram Mohebbi2, Hasan Moladoust3, Majid Haghjoo4, Azin Alizadehasl5, Maryam Esmaeilzadeh6, Sevil Aghapour7, Hooman Bakhshandeh8, Maryam Ardeshiri9, Masoumeh Hamidian10. 1. Professor, Echocardiography Research Center, Rajaie Cardiovascular Medical & Research Center, Iran University of Medical Sciences, Tehran, Iran. 2. M.D., Assistant Professor, Interventional Cardiologist, Department of Cardiology, Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran. 3. Ph.D., Associate Professor, Healthy Heart Research Center, Guilan University of Medical Sciences, Rasht, Iran. 4. M.D., FESC, FACC, Associate Professor, Cardiac Electrophysiology Research Center, Rajaie Cardiovascular Medical and Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran. 5. M.D., Associate Professor, Echocardiologist, Department of Cardiology, Department of Cardiology, Echocardiography Research Center, Rajaie Cardiovascular Medical and Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran. 6. M.D., FACC, FCAPSC, Associate Professor, Echocardiologist, Department of Cardiology, Echocardiography Research Center, Rajaie Cardiovascular Medical and Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran. 7. M.D., Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran. 8. M.D., Ph.D., Associate Professor, Epidemiologist, Cardiovascular Intervention Research Center, Rajaie Cardiovascular Medical and Research Center, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran. 9. M.D., Assistant Professor of Endocrinology and Metabolism, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran. 10. B.Sc. of Nursing, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Abstract
BACKGROUND AND AIM: Effects of atrial fibrillation (AF) and its ablative treatment on LV torsion have not yet been fully investigated. This study aimed to examine whether AF patterns of LV contraction and its ablative correction can exert a significant impact on LV torsion by velocity vector imaging (VVI). METHODS: This case-control study conducted in Rajaie Cardiovascular, Medical and Research Center between October 2012 and June 2013. Study participants were 30 consecutive patients with symptomatic paroxysmal AF who met the inclusion criteria. The control group included 24 healthy participants with no history of cardiovascular disease. All individuals were in sinus rhythm at the time of echocardiography before and after the ablation procedure. Two-dimensional (2D) and Doppler echocardiography on a commercially available ultrasound system was performed for all the patients. Scanning was done by a wide-band ultrasound transducer with the frequency range between 2.5-3.5 MHz. The two short-axis views at basal and apical levels were subsequently processed off-line by VVI XStrain software. In order for data analysis, SPSS 16 utilized using paired and independent t-test. p-value ≤0.05 was considered significant. RESULTS: LV torsion (°/cm) mean ± SD was significantly lower in paroxysmal AF patients before ablation (0.8±0.3) than the control group (1.5±0.4) (p<0.001) and increased significantly after ablation (1.1±0.5) compared with before ablation (p=0.004), but still significantly lower than the control group (p=0.003). LV Twist, twist rate and untwist rate mean ± SD were significantly lower in paroxysmal AF patients before ablation than the control group and increased significantly after ablation compared with before ablation, but still significantly lower than the control group. CONCLUSION: Subclinical LV dysfunction may be detected in paroxysmal AF rhythm by measuring torsional parameters through VVI which improves after AF ablation.
BACKGROUND AND AIM: Effects of atrial fibrillation (AF) and its ablative treatment on LV torsion have not yet been fully investigated. This study aimed to examine whether AF patterns of LV contraction and its ablative correction can exert a significant impact on LV torsion by velocity vector imaging (VVI). METHODS: This case-control study conducted in Rajaie Cardiovascular, Medical and Research Center between October 2012 and June 2013. Study participants were 30 consecutive patients with symptomatic paroxysmal AF who met the inclusion criteria. The control group included 24 healthy participants with no history of cardiovascular disease. All individuals were in sinus rhythm at the time of echocardiography before and after the ablation procedure. Two-dimensional (2D) and Doppler echocardiography on a commercially available ultrasound system was performed for all the patients. Scanning was done by a wide-band ultrasound transducer with the frequency range between 2.5-3.5 MHz. The two short-axis views at basal and apical levels were subsequently processed off-line by VVI XStrain software. In order for data analysis, SPSS 16 utilized using paired and independent t-test. p-value ≤0.05 was considered significant. RESULTS: LV torsion (°/cm) mean ± SD was significantly lower in paroxysmal AFpatients before ablation (0.8±0.3) than the control group (1.5±0.4) (p<0.001) and increased significantly after ablation (1.1±0.5) compared with before ablation (p=0.004), but still significantly lower than the control group (p=0.003). LV Twist, twist rate and untwist rate mean ± SD were significantly lower in paroxysmal AFpatients before ablation than the control group and increased significantly after ablation compared with before ablation, but still significantly lower than the control group. CONCLUSION: Subclinical LV dysfunction may be detected in paroxysmal AF rhythm by measuring torsional parameters through VVI which improves after AF ablation.
Entities:
Keywords:
Left ventricle; Paroxysmal atrial fibrillation; Torsion; Velocity vector imaging
Left ventricular (LV) torsion results from a wringing or twisting motion of the ventricle around its long axis. It is considered as a main contributor to efficient systole and diastole and is, thus, proposed as an indicator for cardiac disease (1, 2). Recently, the assessment of LV torsion has been used as a promising tool to quantify LV function, and it is believed that this parameter may be useful in early detection of cardiac disease and clinical decision making (3, 4). Cardiovascular magnetic resonance (CMR) tissue tagging is currently the gold standard technique for evaluating LV rotational mechanics (5). But recently; speckle-tracking echocardiography has been applied as a simple and direct method in this regard. Using this quantitative technique, which is now validated with tagged magnetic resonance, has improved torsion-related studies (6). Velocity-vector imaging (VVI) is a new angle independent, two-dimensional echocardiographic method that can be employed to determine LV rotational motion and muscle displacement based on feature tracking performed with Fourier techniques in ultrasound and CMR images (7, 8). Atrial fibrillation (AF) is the most common cardiac arrhythmia, and results from electrical and mechanical remodeling even in the absence of structural heart disease. It presents with a wide spectrum of symptoms and severities which need specific approaches to management (9). Pulmonary vein ablation is one choice treatment that achieves the highest cure rate in patients with paroxysmal AF. Some studies have reported that LV torsion is altered under specific physiological and pathological conditions, including normal aging, hypertension, cardiac hypertrophy, cardiomyopathies, ischemia and diabetes (10–16). However, the effects of AF and its ablative treatment on LV rotation and torsion have not yet been fully investigated. This study aimed to examine whether AF patterns of LV contraction and its ablative correction can exert a significant impact on LV torsion by velocity vector imaging (VVI).
2. Material and Methods
2.1. Study Population
This case-control study was conducted in Rajaie Cardiovascular, Medical and Research Center between October 2012 and June 2013. The study subjects were 30 consecutive patients with symptomatic paroxysmal AF, who were candidate for ablation referees to Rajaie Cardiovascular, Medical and Research Center. All the patients had normal ejection fraction (EF>55%). Patients with congestive heart failure, valvular disease, ischemic heart disease, left atrial diameter greater than 55 mm and history of previous ablation procedure were excluded. None of the recruited patients, therefore, had AF due to an underlying structural heart problem. The control group included 24 healthy participants selected from volunteer family members who had no history of cardiovascular disease. All individuals were in sinus rhythm at the time of echocardiography before and after the ablation procedure. Heart rates were similar in control subjects and patients before and after the procedure. Echo studies were performed approximately 24 hours before and after the procedure. Written informed consent was signed by all subjects prior to participation in the study. The study protocol was approved by the institutional review board and local ethics committee.
2.2. Ablation Procedure
The patients were kept on continuous oral anticoagulation with intra-procedural INR levels of 2.0–3.0. Ablation procedures were performed under conscious sedation and using a three-dimensional (3D) mapping system for anatomy and catheter visualization (NavX, St. Jude Medical, St. Paul, MN, USA). The individual left atrial (LA) anatomy, as segmented from the previous CT scan, was displayed during the procedure and fused with the reconstructed anatomy in the 3D mapping system if considered appropriate. For pulmonary vein isolation (PVI), a 10 - polar catheter was placed in the coronary sinus (IBI™, St. Jude Medical, St. Paul, MN, USA), and the LA was accessed via a single trans-septal puncture or via an open foramen oval. After the placement of the electrode catheters within the LA, heparin was given to maintain an activated clotting time of between 300–350 seconds. PVI was performed using an irrigated tip ablation catheter (Therapy Cool Path™, St. Jude Medical, St. Paul, MN, USA). Irrigated radiofrequency (RF) energy with a flow rate of 17ml/min was delivered with a maximum temperature of 43 °C and maximum power of 20–25W until electric PV isolation confirmed with the circular mapping catheter had been achieved.
2.3. Echocardiography
Two-dimensional (2D) and Doppler echocardiography on a commercially available ultrasound system (MyLab60, Esaote Bio., Genova-Italy) was performed for all the patients. Scanning was done by a wide-band ultrasound transducer with the frequency range between 2.5–3.5 MHz (PA230E Esaote Bio., Genova-Italy). LV parasternal short-axis views were obtained at apical and basal levels (mean frame rate=55.3±7.0 fps). The proper basal short-axis level was defined as that containing the mitral valve and the proper apical short-axis level was defined as that containing the LV cavity with no visible papillary muscles and adjacent RV. The LV cross-section was made as circular as possible. A further cine of apical four-chamber and two-chamber views were stored in order to use modified Biplane Simpson’s method to calculate LV ejection fraction (LVEF). End-diastolic LV longitudinal diameter in apical four-chamber view was used to measure LV length. A parasternal long-axis view by M-mode was obtained to measure LV end-diastolic and systolic dimensions and interventricular septal thickness.
2.4. Velocity Vector Imaging (VVI) and Off-Line Analysis
The two short-axis views at basal and apical were subsequently processed off-line by using customized software (VVI XStrain software, Esaote Bio, Genova-Italy). For the initial position of the tracking points based on the American Society Echocardiography’s (ASE) segmentation of the heart, in the end-systolic frame, the aided heart segmentation (AHS) mode was utilized to insert well equal-spaced endocardial tracking points for each 2D short-axis view (17). The software then applied a sequence of processing steps to track the motion of the segments in the other frames automatically. The tissue velocity is displayed as a vector projected on each of the 2D short-axis levels where the vector shows the direction and velocity of the myocardial movement and the rotation of the LV segments around the LV central axis were calculated separately. The data of all the sample regions’ tracking were transferred to a spreadsheet Excel program for LV average rotation and rotational velocity calculation at each short-axis level. Basal and apical rotations were calculated as average angular displacement of six myocardial segments. Counterclockwise LV apical rotation and torsion as viewed from the apex were expressed as positive values, and clockwise LV rotation was expressed as negative value for the basal level. LV twist (degrees) is defined as the instantaneous difference between apical rotation and basal rotation. LV twist was calculated as follows (18, 19): LV Twist (t) = Apical LV rotation(t) − Basal LV rotation(t). Also, LV twist rate (degrees/s) was calculated as follows: LV Twist rate(t) = Apical Vrot(t) − Basal Vrot(t); where Apical Vrot(t) and Basal Vrot(t) are the rotational velocity (degree/s) at the apical and basal levels, respectively. Figure 1 shows LV twist and untwist and Figure 2 demonstrates LV twisting rate and untwisting rate throughout one cardiac cycle. LV peak apical and basal rotations, peak systolic twist, peak twisting rate and peak untwisting rate were measured as is demonstrated in Figures 1 and 2. LV torsion was defined as normalized twist to LV end-diastolic longitudinal length. For all measurements, the average derived from 3 consecutive cardiac cycles were finally used.
Figure 1
LV twist throughout one cardiac cycle in an AF patient. Left, before and right, after ablation
Figure 2
LV twisting and untwisting rate throughout one cardiac cycle in an AF patient. Left, before and right, after ablation
2.5. Statistical Analysis
All the continuous variables were tested for normal distribution via Kolmogorov-Smirnov’s (K-S) test and are presented as mean± standard deviation (SD). The results were compared using paired (before and after ablation) and independent-samples t-test (patients and control). p-value less than or equal to 0.05 was considered the level of statistical significance. Intra-observer variabilities were not different between measurements. All the statistical analyses were performed using SPSS version 16 (SPSS Inc. Chicago, IL, USA).
3. Results
3.1. Clinical and Echocardiographic Characteristics
The present study evaluated 30 patients and 24 healthy subjects. Three patients were excluded due to their poor acoustic windows, leaving 27 patients (15 males and 12 females; Mean age: 45±7 years) and 24 healthy subjects (13 males and 11 females; Mean age: 43±7 years). After AF ablation, all the patients had normal sinus rhythm. The echo findings of the subjects are represented in Table 1. There was no significant difference between the patients and the controls in demographic data. None of the patients experienced an acute complication.
Table 1
The echo findings of the study groups
Variables
Before Ablation
After Ablation
Control
Left ventricular ejection fraction (%)
58±2
59±1
60±2
left atrial diameter (cm)
3.2±0.3
3.3±0.2
3.3±0.3
Left ventricle length (cm)
7.40 ± 0.67
7.37 ± 0.71
7.39 ± 0.64
Left ventricular end-diastolic dimension (cm)
4.7±0.3
4.6±0.2
4.5±0.2
Interventricular septal thickness (cm)
0.78±0.11
0.77±0.12
0.76±0.12
3.2. LV Torsion Parameters
LV torsion parameters are shown in Table 2. The paroxysmal AFpatients had significantly lower LV apical counterclockwise rotation and basal LV clockwise rotation than had the controls (p<0.05). Furthermore, LV twist, twist rate and LV torsion were lower in the paroxysmal AFpatients. After ablation, however, there was a significant increase in the counter-clockwise rotation of the apex as compared with the prior ablation values (p<0.05); such an increase was not noted in the clockwise rotation of the base (p >0.05). A significant increase was also noted while comparing pre- and post-ablation LV twist and twist rate. Moreover, LV torsion increased after the treatment. However, there was still a statistically significant difference between the post-ablation values and the amount measured in the controls (p<0.05). Figures 1 and 2 show LV twist and untwisting rate profiles through one cardiac cycle in a patient before and after ablation. The inter-observer variability for LV twist, torsion, twisting rate and untwisting rate by two independent observers (in 15 randomly selected stored clips) were both blinded to each other’s reading and were 7%, 8%, 10% and 9%, respectively. The intra-observer variabilities (were performed two weeks after the original analysis) for LV twist, torsion, twisting rate and untwisting rate were 5%, 6%, 7% and 7%, respectively.
Table 2
LV torsional parameters in the study groups
Variables (Mean ±SD)
Groups
p-value
Control
Before ablation
After ablation
Patients before ablation vs. Control*
Patients before vs. after ablation**
Patients after ablation vs. Control*
Apical rotation (degree)
7.1±2.2
3.6±1.7
5.1±2.7
<0.001
0.010
0.011
Basal rotation (degree)
−5.2±1.7
−3.4±1.9
−4.0±2.4
0.001
0.215
0.047
Left ventricular twist (degree)
11.1±2.5
5.9±2.4
8.0±3.4
<0.001
0.005
0.001
Left ventricular twist rate (°/s)
75.9±17.3
48.5±13.5
61.4±18.5
<0.001
0.012
0.006
Left ventricular untwist rate (°/s)
−73.8±24.5
−45.4±15.0
−61.2±24.9
<0.001
0.015
<0.001
Left ventricular torsion (°/cm)
1.5±0.4
0.8±0.3
1.1±0.5
<0.001
0.004
0.003
Independent samples t-test,
paired-samples t-test
4. Discussion
Since there were few studies related to the aim of this study, discussion was focused on the few published studies relatively close to the aim of this study. LV torsion may appear as a more sensitive parameter to diagnose LV dysfunction compared with some traditional echocardiographic variables, so LV torsion may be considered as an important diagnostic factor for LV dysfunction (20). The present study was designed to investigate the LV torsional parameters, as assessed by VVI, in paroxysmal AFpatients before and after ablation therapy. We measured LV torsion by dividing the twist by LV length. To eliminate the effect of the confounding factors, only paroxysmal AFpatients with normal heart rate and normal ejection fraction were recruited; whereas we reported an approximate LV twist value of 11.1°±2.5° in our controls. However, different values for LV torsion in normal subjects have been reported in the literature. Peak LV twist calculated in a Sandstede et al. (21) study was 14.5°±3.7°. Data closer to our findings were reported by Young et al. (22) between 12° and 14°, and much lower values were reported by Stuber et al. (23) and Nagel et al. (13). These differences may be due to the different definitions applied for the apical slice, technique and image settings, including focus, sector width, frame rate, gain, etc. Silent arrhythmia is prevalent in AFpatients; the condition is found in the clinical examination of about 20% of patients (24). There are reports of silent arrhythmia in 50% of asymptomatic AFpatients using transtelephonic arrhythmia monitoring or implantable monitoring devices (24, 25). In this study, findings revealed a significant reduction in pre-AF ablation LV basal rotation (to −3.4±1.9°), LV apical rotation (to 3.6°±1.7°) and LV twist value (to 5.9°±2.4°) in patients with paroxysmal AF compared with healthy control subjects despite normal ejection fraction in both groups. It is suggested, changes in LV torsion parameters represent subclinical LV dysfunction in patients with paroxysmal AF even when they are in sinus rhythm. According to our results, apical and basal rotation and torsion values were remarkably lower in the paroxysmal AFpatients than those in the controls. Considering the fact that all our patients had normal EF values, it could be concluded that torsion values are affected earlier than EF values. We suggested that changes in LV torsion parameters represent subclinical LV dysfunction in patients with paroxysmal AF even when they are in sinus rhythm. Different studies showed the value of torsional parameters as a marker of subclinical LV dysfunction in valvular heart disease, as Sandstede et al. (21) assessed LV torsion in patients with aortic stenosis before and after surgical valve replacement. To our knowledge, there is no study in the existing literature to date to measure LV twist/torsion during AF. Our findings similarly indicated that LV torsion was a sensitive marker for early detection of LV dysfunction during AF, and might be used to determine the proper timing of ablation.Recently, there has been an increasing interest in the use of catheter ablation, as a safe and efficient alternative to drug therapy, for the treatment of AFpatients. In our study, LV twist and torsion improved 24 hours after ablation therapy. While the apical counterclockwise rotation values increased during the study, there was no significant increase in the basal clockwise rotation values. Consequently, the effects of ablation therapy were more frequently seen in the apex than the base. LV twist and torsion increased 24 hours following ablation. Whether the reason is an improved atrial contraction or an improved intrinsic LV myocardial function, or as a result of biomarkers, is an unknown and further studies need to be undertaken to find out the answer. The lack of complete improvement in LV twist and torsion, by comparison with the control group, in this study could be due to the fact that these values were measured shortly after ablation. We suggest that torsion be measured in time periods longer than 24 hours after ablation. This rapid change in torsion values also may suggest torsional parameters as a monitoring marker for post ablation AF recurrence. As Hindricks et al. (26) studied the relevance of asymptomatic arrhythmia recurrence after ablation and showed that asymptomatic episodes might occur after catheter ablation. They suggested that if these patients had been followed only based on the symptoms, it might have led to underestimating the rate of recurrences and as a result, recommending long-term Holter monitoring as an objective measure to detect asymptomatic AF recurrences. In this study, our findings suggest that LV torsion might be used for post-ablation monitoring in patients with AF, as any reduction or even lack of improvement in LV torsion after AF ablation might be related to the recurrence of AF following ablation in a structurally normal heart. Since image quality is an important determinant in VVI method, we excluded 3 patients due to poor image quality. Second, peak apical rotation depends markedly on the level of the scanned apex which was specifically addressed by Van Dalen et al. (27). In this study, we tried to obtain the closest plane to the apical obliteration and this limitation can equally influence in a patient at before and after AF ablation apical views. Further investigation with larger number of patients is required to confirm these results. CMR tissue tagging and 3D echocardiography can improve the accuracy of the assessment of LV torsional parameters, but they are not widely available.
5. Conclusions
AF significantly affects LV twist and untwisting rate compared to controls. Moreover, AF ablation leads to significant improvement of apical rotation compared to basal rotation, but the extent of this change significantly differs from controls, concluding AF may result in subclinical LV dysfunction in the presence of normal EF. These data show that apical rotation, twisting and untwisting rate are sensitive markers to detect these abnormalities. Post AF ablation reversible subclinical LV dysfunction may be detected in paroxysmal AF rhythm by measuring torsional parameters through VVI study. LV torsion could be used for post-ablation monitoring in patients with paroxysmal AF, as a decline and lack of improvement in LV torsion after AF ablation might be related to the recurrence of AF following ablation.
Authors: Joost Lumens; Tammo Delhaas; Theo Arts; Brett R Cowan; Alistair A Young Journal: Am J Physiol Heart Circ Physiol Date: 2006-05-05 Impact factor: 4.733
Authors: Yuichi Notomi; Zoran B Popovic; Hirotsugu Yamada; Don W Wallick; Maureen G Martin; Stephanie J Oryszak; Takahiro Shiota; Neil L Greenberg; James D Thomas Journal: Am J Physiol Heart Circ Physiol Date: 2007-11-21 Impact factor: 4.733
Authors: Bas M van Dalen; Wim B Vletter; Osama I I Soliman; Folkert J ten Cate; Marcel L Geleijnse Journal: J Am Soc Echocardiogr Date: 2008-03-20 Impact factor: 5.251
Authors: Thomas Helle-Valle; Jonas Crosby; Thor Edvardsen; Erik Lyseggen; Brage H Amundsen; Hans-Jørgen Smith; Boaz D Rosen; João A C Lima; Hans Torp; Halfdan Ihlen; Otto A Smiseth Journal: Circulation Date: 2005-11-15 Impact factor: 29.690
Authors: Carissa G Fonseca; Ajith M Dissanayake; Robert N Doughty; Gillian A Whalley; Greg D Gamble; Brett R Cowan; Christopher J Occleshaw; Alistair A Young Journal: Am J Cardiol Date: 2004-12-01 Impact factor: 2.778